Related Experiment Videos

Comparative virulence of Streptococcus pneumoniae strains with insertion-duplication, point, and deletion mutations

A M Berry1, A D Ogunniyi, D C Miller

  • 1Molecular Microbiology Unit, Women's and Children's Hospital, North Adelaide, S.A., 5006, Australia.

Infection and Immunity
|January 23, 1999
PubMed

Insights

Streptococcus pneumoniae pneumolysin is a toxin with cytolytic and complement activation properties. A modified strain lacking a key portion of the pneumolysin gene showed reduced virulence, indicating pneumolysin has additional virulence factors.

Area of Science:

  • Microbiology
  • Immunology
  • Toxicology

Background:

  • Pneumolysin is a major virulence factor of Streptococcus pneumoniae.
  • It possesses cytolytic and complement activation properties.
  • The full extent of pneumolysin's role in virulence is not completely understood.

Purpose of the Study:

  • To investigate the role of pneumolysin in Streptococcus pneumoniae virulence.
  • To determine if pneumolysin possesses additional virulence-associated properties beyond cytotoxicity and complement activation.

Main Methods:

  • Construction of a Streptococcus pneumoniae D39 derivative strain (DeltaPly) with an in-frame deletion in the pneumolysin gene (amino acids 55-437).
  • Comparison of the virulence of DeltaPly with wild-type D39, a pneumolysin insertion-duplication mutant (PLN-A), and a mutant with point mutations abolishing cytolytic activity (PdT).
  • Assessment of virulence using a mouse intraperitoneal challenge model.

Main Results:

  • The DeltaPly strain exhibited significantly reduced virulence compared to wild-type D39.
  • The PdT strain, with point mutations, showed intermediate virulence between wild-type and the deletion mutant.
  • These findings suggest pneumolysin has virulence-associated functions independent of its cytolytic and complement-activating activities.

Conclusions:

  • Pneumolysin contributes to Streptococcus pneumoniae virulence through mechanisms beyond its known cytolytic and complement-activating functions.
  • Targeting these additional properties could offer novel therapeutic strategies against pneumococcal infections.

Related Concept Videos